# Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment

> **NCT02400346** · PHASE3 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 132 (actual)

## Conditions studied

- Major Depression Disorder

## Interventions

- **DRUG:** Adjunct brexpiprazole
- **DRUG:** ADT

## Key facts

- **NCT ID:** NCT02400346
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2017-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02400346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02400346, "Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02400346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*